ASCO Guidelines

180 Epizód

1. Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update

   Közzétéve: 2021. 07. 29.
2. Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin

   Közzétéve: 2021. 07. 29.
3. Telehealth in Oncology: Standards and Practice Recommendations

   Közzétéve: 2021. 07. 28.
4. Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline

   Közzétéve: 2021. 07. 20.
5. Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline

   Közzétéve: 2021. 07. 19.
6. Oncology Medical Home: ASCO and COA Standards

   Közzétéve: 2021. 07. 13.
7. Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline

   Közzétéve: 2021. 06. 29.
8. Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update

   Közzétéve: 2021. 05. 03.
9. Management of Salivary Gland Malignancy Guideline

   Közzétéve: 2021. 04. 26.
10. Management of Dyspnea in Advanced Cancer Guideline

    Közzétéve: 2021. 02. 22.
11. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update

    Közzétéve: 2021. 02. 16.
12. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline

    Közzétéve: 2021. 01. 28.
13. Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement

    Közzétéve: 2021. 01. 27.
14. Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

    Közzétéve: 2021. 01. 26.
15. PREVIEW: ASCO in Action CEO & CMO Interview

    Közzétéve: 2021. 01. 19.
16. Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline

    Közzétéve: 2021. 01. 06.
17. Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline

    Közzétéve: 2020. 11. 16.
18. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update

    Közzétéve: 2020. 10. 20.
19. Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline

    Közzétéve: 2020. 10. 01.
20. PARP Inhibitors in the Management of Ovarian Cancer Guideline

    Közzétéve: 2020. 08. 13.